We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Caladrius Licenses Cell Therapy Tech to AiVita

News   May 27, 2016

 
Caladrius Licenses Cell Therapy Tech to AiVita
 
 
 

RELATED ARTICLES

B Cells May Be More Important in Immunotherapy Than Previously Thought

News

Researchers have found evidence that B cells might play an important role in immunotherapy for melanoma. Currently, immunotherapy is primarily focused on T cells, but the results suggest that B cells could also provide an interesting research avenue.

READ MORE

First-of-Its-Kind Study Shows CAR-T Cell Therapy May Be Viable for Heart Disease Treatment

News

In a world first, researchers from Penn Medicine have used genetically modified T cells to target and ablate fibroblasts that contribute to the development of heart disease.

READ MORE

The Impact of Age on Immunotherapy Treatment for Breast Cancer

News

To understand the influence of aging on the effectiveness of immune checkpoint blockade (ICB) therapy, researchers conducted preclinical studies using younger and older mice with triple negative breast cancer, finding that age affects the efficacy of ICB therapy.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE